MMedication Read More Ozempic, Wegovy list prices to be slashed by up to 50%February 27, 2026 Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50%…
MMedication Read More 1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market CrashFebruary 26, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
HHealthcare Read More Novo Nordisk announces significant reduction in US list price for Wegovy®, Ozempic®, and Rybelsus® (semaglutide medicines), building on continued efforts to expand accessFebruary 25, 2026 New, lower list price of $675 per month across Wegovy®, Ozempic®, and Rybelsus®, effective January 1, 2027, addresses…
MMedication Read More NHS must keep medicine rebate down or lose investmentFebruary 19, 2026 Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
MMedication Read More Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasibleFebruary 18, 2026 HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
HHealthcare Read More What’s the Better Long-Term Investment?February 10, 2026 Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are rivals in the GLP-1 drug market and are…
HHealthcare Read More Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.February 8, 2026 Eli Lilly’s (NYSE: LLY) stock has risen 225% over the past three years. That trounces the S&P 500’s (SNPINDEX:…
HHealthcare Read More The most controversial Super Bowl ad of 2025 is back for moreFebruary 7, 2026 Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
HHealthcare Read More Novo Nordisk says Hims & Hers’ cheaper version of Wegovy pill is illegalFebruary 6, 2026 In an unexpected move, Hims & Hers is making available a cheaper, compounded version of the Wegovy weight…
MMedication Read More Hims and Hers Health’s compounded Wegovy pill offering fuels market jittersFebruary 5, 2026 Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…
MMedication Read More Hims launches $49 compounded copy of Wegovy weight-loss pillFebruary 5, 2026 By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
MMedication Read More SA sales of weight-loss drugs surge amid global rise in lawsuitsFebruary 5, 2026 Sales of weight-loss drugs are sky-rocketing in South Africa, as it has in other parts of the world.…